March 12, 2020

Patient Safety Movement Foundation Appoints New Chairman;...

Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/......

Read More >
March 12, 2020

First Health Centre Opens in Yemen’s Largest Displacement...

Five years of fighting have taken their toll on Yemen’s health infrastructure, which today operates at half the capacity it had prior to the conflict so the International Organization for Migration’s (IOM) opening on Sunday (08/03) of a health centre in the Al Jufainah Camp"...

Read More >
March 12, 2020

Australia unveils $1.6 billion health package to combat...

Australia announced on Wednesday a health package worth A$2.4 billion ($1.56 billion) that proposes setting up fever clinics, among other measures to rein in the spread of a coronavirus, as it prepares to announce further stimulus.

Australia has been struggling to contain the"...

Read More >
March 12, 2020

Vifor Pharma Group Reports Strong Growth in 2019, Exceeding...

Regulatory News:

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded"...

Read More >
March 11, 2020

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2......

Read More >
March 11, 2020

Sinterex named Best 3D-Printed Healthcare Products Manufacturer...

Global Health & Pharma (GHP), a global information sharing platform & a multi-disciplinary members community announced winners of the 2019 Technology Awards this month and recognised Sinterex as Best 3D-Printed Healthcare Products Manufacturer – Middle East.

In"...

Read More >
March 10, 2020

Yemen: Thousands of people in need of food and shelter as...

Intense fighting on the frontline between Sanaa and Al Jawf Governorate in Northern Yemen has displaced tens of thousands of people to Marib Governorate, leaving families without food, shelter, and access to medical care.

Marib"...

Read More >
March 9, 2020

Takeda Initiates Development of a Plasma-Derived Therapy...

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19, while also studying whether Takeda’s currently marketed and pipeline products may be effective treatments for infected patients. SARS-CoV-2 is the virus that causes COVID-19. Hyperimmune globulins are plasma derived-therapies that have previously been shown to be effective in the treatment of severe acute viral respiratory infections and may be a treatment......

Read More >
March 8, 2020

Higher Committee for Epidemics Control decides to examine...

SANAA, March 7 (Saba) – The Higher Committee for Epidemics Control on Saturday, at its meeting chaired by Deputy Prime Minister for Services and Development Affairs Dr. Hussein Maqbouli, approved the examination procedure for all arrivals to Yemen without exception, including the"...

Read More >
March 8, 2020

WHO says risk of coronavirus spread is ''very high at a...

SANAA, March 8 (Saba) -The World Health Organization has announced the coronavirus outbreak has reached the “highest level” of risk for the world.

Coronavirus was first detected in December 2019 in"...

Read More >

Most Popular Articles



Forex News Headline

Found articles: - Pages